| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/01/2013 | US8546089 CMYBP-C and MLC2 as diagnostic markers of cardiac injury |
| 10/01/2013 | US8546088 Porphyrinic compounds for use in flow cytometry |
| 10/01/2013 | US8546087 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention |
| 10/01/2013 | US8546086 Use of neuregulin-β as an indicator and/or target |
| 10/01/2013 | US8546085 Methods of identifying modulators of the bitter taste receptor TAS2R44 |
| 10/01/2013 | US8546084 Device and method for identifying and determining blood groups |
| 10/01/2013 | US8546081 Methods and compositions for assaying a sample for an aggregant |
| 10/01/2013 | US8546080 Molecular dispensers |
| 10/01/2013 | US8546079 Reporter gene construct, assay kit and detection method |
| 10/01/2013 | US8546075 Method of detecting hepatitis C virus |
| 10/01/2013 | US8546074 Sir2 activity |
| 10/01/2013 | US8546072 Substrate for assaying β-glucan and/or endotoxin and assay method |
| 10/01/2013 | US8545814 Non-invasive localization of a light-emitting conjugate in a mammal |
| 10/01/2013 | US8545768 Test sensor package |
| 10/01/2013 | US8545762 Sensor for detecting compounds |
| 10/01/2013 | US8545758 Microparticle sorting apparatus, flow cytometer using the same and microparticle sorting method |
| 10/01/2013 | US8545756 Assay system |
| 10/01/2013 | US8545693 Analyte measurment method and system |
| 10/01/2013 | US8544351 Method and apparatus for characterizing the flowability of toner particles |
| 10/01/2013 | CA2689741C Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 10/01/2013 | CA2685997C Compositions and methods for combining report antibodies |
| 10/01/2013 | CA2675103C Micro-array analysis system and method thereof |
| 10/01/2013 | CA2611091C Biosensor strips and methods of preparing same |
| 10/01/2013 | CA2586447C Pharmaceutical analysis apparatus and method |
| 10/01/2013 | CA2558612C Method and antibodies for detecting milk allergens |
| 10/01/2013 | CA2522060C Fragments of fluorescent proteins for protein fragment complementation assays |
| 10/01/2013 | CA2495456C Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 10/01/2013 | CA2485602C System and methods for rapid and automated screening of cells |
| 10/01/2013 | CA2481515C Anti-her2 antibody variants |
| 10/01/2013 | CA2479835C An ephrin-b receptor protein involved in carcinoma |
| 10/01/2013 | CA2470115C Volatile organic compound sensor system |
| 10/01/2013 | CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase |
| 10/01/2013 | CA2454873C Novel transformed cell, method for screening anti-aging agent, and anti-aging agent |
| 10/01/2013 | CA2436530C Environmentally regulated genes of streptococcus suis |
| 10/01/2013 | CA2433296C Focused acoustic ejection cell sorting system and method |
| 10/01/2013 | CA2408038C Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 10/01/2013 | CA2366520C Anti-bacterial vaccine compositions |
| 09/30/2013 | CA2772889A1 Real time multipoint assay for optimizing performance |
| 09/28/2013 | CA2773151A1 Cancer diagnostic kit to monitor the activity of protein kinase ck2, the methods and compositions thereof |
| 09/27/2013 | WO2012128898A1 Multisignal labeling reagents and processes and uses therefor |
| 09/27/2013 | CA2827754A1 Multisignal labeling reagents and processes and uses therefor |
| 09/26/2013 | WO2013142857A1 Methods for determining functional antibodies |
| 09/26/2013 | WO2013142847A1 Pdms membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them |
| 09/26/2013 | WO2013142758A1 Compositions and methods for in vitro diagnostic tests including sulfonic acid |
| 09/26/2013 | WO2013142716A1 Lipid arrays on fabricated devices and uses thereof |
| 09/26/2013 | WO2013142571A2 Assays for the identification of compounds that modulate lipid homeostasis |
| 09/26/2013 | WO2013142477A1 Methods for treating and monitoring the status of cancer |
| 09/26/2013 | WO2013142330A1 Methods of identifying hit-antibodies and pf4 antagonists and cell lines for use therein |
| 09/26/2013 | WO2013142303A1 Methods and compositions for detecting immune system activation |
| 09/26/2013 | WO2013142298A1 Stable peptide mimetics of the hiv-1 gp41 pre-hairpin intermediate |
| 09/26/2013 | WO2013142200A1 Peptide with gold binding and egfr receptor affinity and same attached to gold nanostructure |
| 09/26/2013 | WO2013142155A1 Methods and compositions for detecting endometrial or ovarian cancer |
| 09/26/2013 | WO2013142003A1 Biologic machines for the detection of biomolecules |
| 09/26/2013 | WO2013141945A1 Semi-quantitative lateral flow assays |
| 09/26/2013 | WO2013141845A1 Genomics-based alerting systems |
| 09/26/2013 | WO2013141816A1 A method of diagnosing and/or treating corneal fibrosis |
| 09/26/2013 | WO2013141752A1 Mobile radio device with a measuring device for measuring the quantity of alcohol in exhaled air |
| 09/26/2013 | WO2013141716A1 Biomarkers |
| 09/26/2013 | WO2013141636A1 Apparatus for arranging tubes for manufacturing blood collection tubes |
| 09/26/2013 | WO2013141610A1 Analysis device |
| 09/26/2013 | WO2013141414A1 Method for compensating output signal of optical biosensor and optical biosensor using the same |
| 09/26/2013 | WO2013141372A1 Fret measurement device and fret measurement method |
| 09/26/2013 | WO2013141368A1 Fret measurement device and fret measurement method |
| 09/26/2013 | WO2013141291A1 Device for target analysis of streptavidin, and analysis method |
| 09/26/2013 | WO2013141266A1 Method for detecting novel ret fused body |
| 09/26/2013 | WO2013141260A1 Speed reducer breakage state-informing device, machine system with speed reducer breakage state-informing function, and medium having speed reducer breakage state-informing program recorded thereon |
| 09/26/2013 | WO2013141223A1 Yogurt firmness evaluation method and yogurt firmness evaluation device |
| 09/26/2013 | WO2013141202A1 Muscle-building agent and screening method for muscle-building substance |
| 09/26/2013 | WO2013141122A1 Immunochromatography detection method |
| 09/26/2013 | WO2013141103A1 Stool assay kit |
| 09/26/2013 | WO2013141092A1 Cancer metastasis marker and method for diagnosing cancer metastasis using same |
| 09/26/2013 | WO2013140927A1 Method for screening therapeutic and/or prophylactic agents for alzheimer's disease |
| 09/26/2013 | WO2013140843A1 Measurement method and device, for determining degree of engine oil dilution by fame |
| 09/26/2013 | WO2013140785A1 Apparatus, system and method for analyzing disease sample |
| 09/26/2013 | WO2013140681A1 Device for target analysis, and analysis method |
| 09/26/2013 | WO2013140629A1 Atp or amp analysis device and analysis method |
| 09/26/2013 | WO2013140349A1 A method and a kit for the detection of anti-beta amyloid antibodies |
| 09/26/2013 | WO2013140335A1 Hb-egf inhibitor derived from the r domain of diphtheria toxin for the treatment of diseases associated with the activation of the hb-egf/egfr pathway |
| 09/26/2013 | WO2013140103A1 Process for determining the susceptibility to nosocomial infections |
| 09/26/2013 | WO2013140089A1 Device for determining at least one analyte capable of being contained in a liquid sample |
| 09/26/2013 | WO2013140074A1 Method for determining the ability of an antibody to keep cells close to one another |
| 09/26/2013 | WO2013140020A1 Portable device assembly for measuring blood samples and a device cover |
| 09/26/2013 | WO2013139993A1 Peptide-based f-actin affinity matrix |
| 09/26/2013 | WO2013139972A1 Method for monitoring hiv specific t cell responses |
| 09/26/2013 | WO2013139895A1 Diagnostic method |
| 09/26/2013 | WO2013139728A1 Glatiramer acetate human monocyte cell-based potency assay |
| 09/26/2013 | WO2013139709A1 Method and device for the nondestructive testing of the material integrity of a composite part, in particular in the hollows thereof |
| 09/26/2013 | WO2013139676A1 Transgenic animal model of mood disorders |
| 09/26/2013 | WO2013139584A1 Hydroxy-sphingomyelin 22:1 as biomarker for healthy ageing |
| 09/26/2013 | WO2013139583A1 P-cresol sulphate as biomarker for healthy ageing |
| 09/26/2013 | WO2013139582A1 1-o-alkyl-2-acylglycerophosphocholine (pc-o) 40:1 as biomarker for healthy ageing |
| 09/26/2013 | WO2013139580A1 Phenylacetylglutamine as biomarker for healthy ageing |
| 09/26/2013 | WO2013139579A1 9-oxo-octadecadienoic acid (9-oxo-hode) as as biomarker for healthy ageing |
| 09/26/2013 | WO2013139555A1 Cryoembedded cell concentrates, methods for making, and methods for using |
| 09/26/2013 | WO2013139478A1 Profiling oligosaccharides associated with biological activities of heparin or heparin derivatives |
| 09/26/2013 | WO2013139348A1 Skin cancer biomarker detection by infrared spectroscopy |
| 09/26/2013 | WO2013139339A1 Hcv full-length infectious cell culture systems and applications thereof |
| 09/26/2013 | WO2013138909A1 Detection and modulation of rheumatoid arthritis |
| 09/26/2013 | WO2013116834A3 Device and kit to simulate post ischemic stroke conditions |
| 09/26/2013 | WO2013115897A9 Pathogen detection using metal enhanced fluorescence |